Correlation Between Kilitch Drugs and Mangalam Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kilitch Drugs and Mangalam Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kilitch Drugs and Mangalam Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kilitch Drugs Limited and Mangalam Drugs And, you can compare the effects of market volatilities on Kilitch Drugs and Mangalam Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kilitch Drugs with a short position of Mangalam Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kilitch Drugs and Mangalam Drugs.

Diversification Opportunities for Kilitch Drugs and Mangalam Drugs

0.77
  Correlation Coefficient

Poor diversification

The 3 months correlation between Kilitch and Mangalam is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Kilitch Drugs Limited and Mangalam Drugs And in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mangalam Drugs And and Kilitch Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kilitch Drugs Limited are associated (or correlated) with Mangalam Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mangalam Drugs And has no effect on the direction of Kilitch Drugs i.e., Kilitch Drugs and Mangalam Drugs go up and down completely randomly.

Pair Corralation between Kilitch Drugs and Mangalam Drugs

Assuming the 90 days trading horizon Kilitch Drugs Limited is expected to generate 2.65 times more return on investment than Mangalam Drugs. However, Kilitch Drugs is 2.65 times more volatile than Mangalam Drugs And. It trades about 0.03 of its potential returns per unit of risk. Mangalam Drugs And is currently generating about -0.05 per unit of risk. If you would invest  30,450  in Kilitch Drugs Limited on August 29, 2024 and sell it today you would earn a total of  305.00  from holding Kilitch Drugs Limited or generate 1.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Kilitch Drugs Limited  vs.  Mangalam Drugs And

 Performance 
       Timeline  
Kilitch Drugs Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kilitch Drugs Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.
Mangalam Drugs And 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mangalam Drugs And has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's essential indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Kilitch Drugs and Mangalam Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kilitch Drugs and Mangalam Drugs

The main advantage of trading using opposite Kilitch Drugs and Mangalam Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kilitch Drugs position performs unexpectedly, Mangalam Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mangalam Drugs will offset losses from the drop in Mangalam Drugs' long position.
The idea behind Kilitch Drugs Limited and Mangalam Drugs And pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Transaction History
View history of all your transactions and understand their impact on performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation